Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival-Reference-Cited by-同舟云学术

Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival

Published:2014-02-27 Issue:11 Volume:120 Page:1677-1685
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Cohen Jonathon B.¹,Geyer Susan M.¹,Lozanski Gerard²,Zhao Weiqiang²,Heerema Nyla A.¹²,Hall Nathan C.³,Nagar Veena A.³,Hemminger Jessica A.²,Jones Jeffrey A.¹,Porcu Pierluigi¹,Christian Beth A.¹,Baiocchi Robert A.¹,Maddocks Kami J.¹,Flynn Joseph M.¹,Devine Steven M.¹,Blum Kristie A.¹

Affiliation:

1. Division of Hematology; The Ohio State University-James Comprehensive Cancer Center; Columbus Ohio

2. Department of Pathology; The Ohio State University-James Comprehensive Cancer Center; Columbus Ohio

3. Department of Radiology; The Ohio State University-James Comprehensive Cancer Center; Columbus Ohio

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28642/fullpdf

Reference20 articles.

1. MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy;Savage;Blood,2009

2. MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation;Cuccuini;Blood,2012

3. Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone;Johnson;J Clin Oncol,2012

4. MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma;Horn;Blood,2013

5. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma;Snuderl;Am J Surg Pathol,2010

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Classification of Diffuse Large B Cell Lymphoma;Advances in Molecular Pathology;2023-11

2. Results of treatment with alemtuzumab in a Spanish cohort of patients with multiple sclerosis in the real world: The RealMS study;Frontiers in Neurology;2023-03-14

3. High-intensity chemotherapy improved the prognosis of patients with high-grade B-cell lymphoma;Frontiers in Immunology;2022-12-23

4. Favorable Outcomes with R-CHOP Induction and Consolidative Autologous Stem Cell Transplantation for Double-Hit Lymphoma;Transplantation and Cellular Therapy;2022-11

5. First‐line treatment of double‐hit and triple‐hit lymphomas: Survival and tolerance data from a retrospective multicenter French study;American Journal of Hematology;2020-12-29